TX-MARY-KAY
30.8.2022 16:26:37 CEST | Business Wire | Press release
We all have a responsibility to care for the environment and the world around us. Sustainability must be a concerted effort and a global commitment. In late June, the Sustainable Future International Conference, sponsored by Mary Kay Inc., took place at the historic Martinic Palace, a UNESCO World Heritage site. Thought leaders, experts, businesses, and non-profit executives from several industries descended on the historical grounds to share, network, and educate audiences on innovative and sustainable standards to successfully implement in the fight to preserve the world’s precious resources for current and future generations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220830005153/en/
“Because of our global footprint, we know our moral imperative is to continue Mary Kay’s legacy of doing the right thing – today, tomorrow, always. We are focused on efficient manufacturing operations by reducing our environmental impact and identifying opportunities for resource improvement. We are challenging ourselves to further entrench sustainable practices in our business through product development, design, responsible sourcing, and mitigation of plastic pollution,” said Edita Szaboova, General Manager of Mary Kay Czech Republic and Slovakia. (Photo Credit: Mary Kay Inc.)
Mary Kay Inc., a long-time advocate for sustainability, preempted the event by announcing its new sustainability strategy in 2021: Enriching Lives Today for a Sustainable Tomorrow. Enriching Lives Today for a Sustainable Tomorrow was developed with the company’s key stakeholders and is aligned with the United Nations’ Sustainable Development Goals, making Mary Kay a key part of a global coalition to effect change for a better future.
The Sustainable Future International Conference was organized by Startup Disrupt, a global marketplace for startup companies that want to help a new generation of startup founders, engineers, developers, tech innovators, and others to succeed. The event focused on the topics of smart cities (infrastructure, development), electromobility (e-mobility, energy & renewable resources, economy & policy), sustainable business (environment, taxonomy, sustainable finance), and sustainable life (agrotech, food waste, fashion disrupt, smart farming).
Speakers with diverse backgrounds and experiences shared their wisdom at the Sustainable Future conference and represented various sectors such as startup founders, executives from large and small companies, ministries, associations, unions, chambers, investment groups, policymakers (European Commission), scientific and research institutes, universities, and non-profit.
“Mary Kay’s global sustainability strategy, Enriching Lives Today for a Sustainable Tomorrow, is anchored in the three dimensions of sustainable development—economic, environmental, and social,” said Edita Szaboova, General Manager of Mary Kay Czech Republic and Slovakia. “Because of our global footprint, we know our moral imperative is to continue Mary Kay’s legacy of doing the right thing – today, tomorrow, always. We are focused on efficient manufacturing operations by reducing our environmental impact and identifying opportunities for resource improvement. We are challenging ourselves to further entrench sustainable practices in our business through product development, design, responsible sourcing, and mitigation of plastic pollution.”
“There is no Planet B! We should always keep this motto in mind. Within the European Union, many companies focus on sustainable business practices. At the Sustainable Future International Conference, we showed the best of what we have achieved here in the Czech Republic and at the same time, we inspired best practices around the world. Mary Kay with its strong vision in sustainability is an emerging force to partner with,” said Patrik Juránek, Founder and CEO of Startup Disrupt.
The next summit hosted by Startup Disrupt will take place in the Czech Republic on September 13 at Clam-Gallas Palace in Prague. The summit’s theme is Diversity which will bring together more than 50 keynote speakers from a variety of Czech and global brands. Speakers and thought leaders will participate in discussion panels on a wide array of Diversity, Equity, and Inclusion (DEI) topics: Biases and Microaggression; Employment of People with Disabilities; Inclusive Design and Innovation, and Women’s Empowerment, just to name a few. Mary Kay Inc. Global Head of Sustainability and Social Impact, Virginie Naigeon-Malek will speak at the summit on the topic of women’s empowerment and gender-responsive procurement as a powerful strategy for inclusive sustainable growth.
“Globally, 1 in 3 businesses are owned by women. Yet, on average, women-owned businesses globally win less than 1% of all procurement spending by large corporations and governments,” said Virginie Naigeon-Malek. “These two stats are two sides of the same coin: the shocking reality on one slide and the tremendous opportunity ahead on the other. Effective procurement policies and practices can be used as a powerful strategy to support women entrepreneurs in our effort to build back from the economic impacts of the pandemic, and re-think business practices with a DEI mindset – to shift towards inclusive growth. This massive gap in representation brings the opportunity to advance action to support women’s businesses across the globe - a unique opportunity to not only build back better but, most importantly, to build back equal.”
ABOUT MARY KAY
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors of domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
ABOUT STARTUP DISRUPT
Startup Disrupt was founded in 2020 and is dedicated to helping business and tech disrupters to change the ‘old’ way of thinking in industries, products, and services. The idea has been built by people from global entrepreneur communities and startup enthusiasts. The purpose of Startup Disrupt is to become a startup platform designed to provide knowledge, inspiration, and connection to entrepreneurs, startup founders, technology innovators, and startup communities all over the world. For more information, visit https://www.startupdisrupt.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220830005153/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom